TABLE 5.
Comparison of patient background, operative complications, and functional outcome with previous research.
| Author | Disease | n | Age* | Use of TNFα | Use of steroid | Approach/construction method | Operative time* (min) | Blood loss* (mL) | CD Grade | AL | SBO | Post‐op Hospital stay* (day) | Readmission | Follow‐up* (years) | Pouch failure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Saigusa N, et al 31 2000 |
UC/FAP | 3 | 32.7 | N.A. | N.A. |
Open/IPAA (Handsewn/stapled) |
N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. |
| Kawamura J, et al 23 2013 | UC | 28 | 35 | 0 | 46.0% |
Lap/TA‐IPAA (Handsewn) |
440 | 80–140 |
≥II 57.1% ≥III 17.9% |
3.6% | 42.9% | N.A. | N.A. | N.A. | 7.1% |
| Tasende MM, et al 19 2015 | UC | 16 | N.A. | N.A. | N.A. |
Lap/IPAA (Handsewn/stapled) |
170 | N.A. | Total 37.5% | 0.0% | 6.3% | 7 | N.A. | 1.9 | 0% |
|
C. A. Leo, et al 4 2015 |
UC | 16 | 46 | 0 | 12.5% |
Lap/IPAA (Handsewn/stapled) |
247 | N.A. | Total 43.8% | 6.2% | 25.0% | 6 | N.A. | N.A. | N.A. |
|
P. Ambe, et al 21 2017 |
FAP | 8 | 19 | 0 | 0.0% |
Lap/TAn IPAA (stapled) |
470 | N.A. | Total 12.5% | 25.0% | N.A. | 13 | 12.5% | N.A. | 12.5% |
|
de Buck van Overstraeten, et al 7 2017 |
UC/IBDU | 216 | 37 | 13.4% | 9.7% |
Lap or Robot/IPAA TAn 97 TA 119 |
218 | N.A. |
≥II 1.9% ≥III 17.5% (TAn) |
7.4% | N.A. |
TA 9, TAn 7 |
N.A. | N.A. | N.A. |
|
Lask A, et al 20 2021 |
UC | 22 | 32 | N.A. | N.A. |
Lap/Tan‐IPAA (Handsewn/stapled) |
N.A. | N.A. | ≥II 22% | 9.0% | N.A. | N.A. | N.A. | 1.3 | 21.4% |
|
Park L, et al. 8 2022 |
UC | 113 | 36.5 | 11.2% | N.A. |
Lap/Tan‐IPAA (Handsewn/stapled) |
320 | N.A. |
≥II 43.4% ≥III 18.4% |
Handsewn 14.3%, Stapled 5% |
21.1% |
TA4, TAn 3.3 |
TA 27%, TAn 26% |
N.A. | 0.9% |
|
Fukui R, et al 32 2023 |
UC/FAP | 32 | 50.5 | N.A. | N.A. |
Lap/IPAA (Handsewn/stapled) |
N.A. | N.A. |
≥II 77.8% ≥III 16.7% |
N.A. | N.A. | N.A. | N.A. | 4.6 | 31.3% |
| Current study | UC | 37 | 35 | 67.6% | 73.0% |
Lap/TAn‐IPAA (TAMIP) |
289 | 130 |
≥II 29.7% ≥III 8.1% |
8.1% (Handsewn) |
10.8% | 8 | 8.1% | 4.0 | 8.2% |
| Current study | UC | 7 | 52 | 71.4% | 71.4% | Lap/TA‐IPAA | 443 | 392 |
≥II 57.1% ≥III 28.6% |
42.9% (Handsewn) |
28.6% | 18 | 57.1% | 7.0 | 28.6% |
Abbreviations: AL, anastomotic leakage; CD, Clavien–Dindo; FAP, familial adenomatous polyposis; IBDU, inflammatory bowel disease unclassified; IPAA, ileal pouch‐anal anastomosis; Lap, laparoscopic surgery; Ro, robot‐assisted surgery; SBO, small bowel obstruction; TA, transabdominal; TAMIP, transanal minimally invasive proctectomy; TAn, transanal; UC, ulcerative colitis.
Median.